Camber Capital Management as of June 30, 2019
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 29 positions in its portfolio as reported in the June 2019 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Allergan SHS | 13.7 | $293M | 1.8M | 167.43 | |
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 13.7 | $293M | 1.0M | 293.00 | |
Mylan N V Shs Euro Call Option | 10.9 | $233M | 12M | 19.04 | |
DaVita (DVA) | 5.2 | $113M | 2.0M | 56.26 | |
Perrigo SHS (PRGO) | 4.4 | $95M | 2.0M | 47.62 | |
Brookdale Senior Living (BKD) | 4.2 | $90M | 13M | 7.21 | |
Nektar Therapeutics (NKTR) | 4.1 | $89M | 2.5M | 35.58 | |
Universal Hlth Svcs CL B (UHS) | 4.0 | $85M | 650k | 130.39 | |
Hca Holdings (HCA) | 3.8 | $81M | 600k | 135.17 | |
Sarepta Therapeutics (SRPT) | 3.5 | $76M | 500k | 151.95 | |
Ascendis Pharma A S Sponsored Adr (ASND) | 3.5 | $75M | 650k | 115.15 | |
Gilead Sciences (GILD) | 3.1 | $68M | 1.0M | 67.56 | |
Medicines Company | 2.9 | $62M | 1.7M | 36.47 | |
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 2.8 | $60M | 6.5M | 9.23 | |
Zymeworks | 2.7 | $57M | 2.6M | 22.00 | |
Alexion Pharmaceuticals | 2.4 | $52M | 400k | 130.98 | |
Tenet Healthcare Corp Com New (THC) | 2.4 | $52M | 2.5M | 20.66 | |
Bristol Myers Squibb (BMY) | 2.1 | $45M | 1.0M | 45.35 | |
Momenta Pharmaceuticals | 2.0 | $44M | 3.5M | 12.45 | |
Atara Biotherapeutics | 1.9 | $40M | 2.0M | 20.11 | |
AMAG Pharmaceuticals | 1.4 | $30M | 3.0M | 9.99 | |
United Therapeutics Corporation (UTHR) | 1.3 | $29M | 368k | 78.06 | |
Synthorx | 1.2 | $25M | 1.9M | 13.51 | |
Glaxosmithkline Sponsored Adr | 0.9 | $20M | 500k | 40.02 | |
Cyclerion Therapeutics | 0.8 | $18M | 1.6M | 11.45 | |
Tg Therapeutics (TGTX) | 0.4 | $8.7M | 1.0M | 8.65 | |
Sutro Biopharma (STRO) | 0.3 | $6.8M | 600k | 11.38 | |
Alkermes SHS (ALKS) | 0.2 | $4.2M | 188k | 22.54 | |
Surgery Partners (SGRY) | 0.1 | $1.3M | 160k | 8.14 |